Related Experiment Video
Updated: May 30, 2026
08:49
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Survey of public domain software for docking simulations and virtual screening
Jacek Biesiada1, Aleksey Porollo, Prakash Velayutham
1Biomedical Informatics, Children's Hospital Research Foundation, Cincinnati, OH 45229, USA.
Human Genomics
|August 3, 2011
Summary
Computational drug discovery is advancing with improved molecular docking software. This review surveys tools like DOCK and AutoDock Vina, assessing their performance in predicting drug-target interactions for therapeutic development.
Area of Science:
- Computational chemistry
- Drug discovery
- Structural biology
Background:
- Functional genomics and structural studies identify new therapeutic targets.
- Computational approaches are crucial for small molecule docking and virtual screening.
- Advancements in computational methods are vital for modern drug development.
Purpose of the Study:
- To survey recent improvements in public domain molecular docking software.
- To evaluate methods for analyzing and visualizing docking simulations.
- To assess the performance and limitations of current docking programs using a benchmark dataset.
Main Methods:
- Review of public domain docking packages: DOCK, AutoDock, AutoDock Vina, and SLIDE.
- Survey of methods for docking simulation analysis and visualization.
- Application of the NCTR oestrogen receptor benchmark set (232 compounds) to test docking programs.
Main Results:
- Tested docking programs showed a correlation coefficient of up to 0.6.
- This indicates moderate success in predicting binding affinities for active compounds.
- Performance and limitations of current docking programs were illustrated.
Conclusions:
- Current molecular docking tools show promise but have limitations in accurately predicting binding affinities.
- Further improvements in docking algorithms and analysis methods are needed for robust drug development.
- The NCTR oestrogen receptor benchmark is a valuable resource for evaluating docking software performance.
